Results 281 to 290 of about 1,772,507 (392)
This study presents a nanoparticle‐embedded nanofiber (5F/STFM/R‐ES) to inhibit melanoma growth and reduce the risk of metastasis and recurrence. The drug delivery system induces ferroptosis and potentiates immunotherapy through resiquimod (R848) and Fe/Mn‐based metal‐polyphenol networks (TFM).
Mingyang Li +10 more
wiley +1 more source
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union. [PDF]
Loedy N +11 more
europepmc +1 more source
The Treatment of Mediterranean Fever by means of Vaccines, with Illustrative Cases [PDF]
Fleet-Surgeon P.W. Bassett-Smith
openalex +1 more source
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
W. Lee, A. Wheatley, S. Kent, B. Dekosky
semanticscholar +1 more source
This study developed mAb‐5F2, a monoclonal antibody targeting conserved GP4 residues (Q48/I50), which blocks the GP4‐CD163 interaction, resulting in a 78–85% reduction in viral entry. Porcineized 5F2‐pFc prevented mortality in infected piglets, reduced pulmonary viral loads, and minimized lesions. This broad‐spectrum antibody platform overcomes vaccine
Xu Chen +12 more
wiley +1 more source
Challenges and recommendations of vaccination in immunosuppression. [PDF]
Martins CAO +3 more
europepmc +1 more source
Recent Advances in Vaccine and Serum Therapy. [PDF]
Alexander Fleming, George Petrie
openalex +1 more source
B‐EPIC: A Transformer‐Based Language Model for Decoding B Cell Immunodominance Patterns
B‐Epic: Achieving high‐accuracy B cell epitope prediction through Transformer architecture. Comprehensive validation demonstrates B‐Epic's robust performance across diverse datasets. B‐Epic facilitates vaccine development for H. pylori and EBV, addressing critical public health challenges.
Jun‐Ze Liang +16 more
wiley +1 more source
Resilience, perceived control, and intention to receive additional vaccines for COVID-19 among healthcare university students: Mediating role of knowledge of vaccine and infection-preventive behaviors. [PDF]
Kondo A +4 more
europepmc +1 more source

